Elaboration of the technology of producing a lyophilized form of immunoglobulin preparations for intravenous administration
Kiseleva, I.A.; Anastasiev, V.V.; Novikova, L.P.; Voronova, E.A.; Kartavina, G.I.
Gematologiia i Transfuziologiia 35(5): 32-34
1990
ISSN/ISBN: 0234-5730 PMID: 2394359 Document Number: 355539
Document emailed within 1 workday
Related Documents
Mikhaĭlitsyn, F.S.; Petrov, I.F.; Bol'shakova, A.I.; Lebedeva, M.N.; Lychko, N.D. 1995: The technology for manufacturing antiparasitic preparations. 4. the development of a technology for producing the anthelmintic bromoksan in finely dispersed form and the evaluation of its antifascioliasis activity Meditsinskaia Parazitologiia i Parazitarnye Bolezni 3: 41-42Mikhaĭlitsyn, F.S.; Drusviatskaia, S.K.; Uvarova, N.A.; Taits, S.Z.; Stoianovich, F.M.; Vol'kenshteĭn, I.B.; Lebedeva, M.N.; Krotov, A.I.; Lychko, N.D. 1994: The technology for manufacturing antiparasitic preparations. 3. the development of a technology for producing the anthelmintic embovin (pyrantel embonate) in finely dispersed form and the evaluation of its anthelmintic properties Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2: 24-26
Barban, P.S. 1976: The complex technology of producing rickettsial diagnostic immunoglobulin preparations and comparative technico-economic indices Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 45-49
Börner, P.; Deicher, H.; Bähr, I.; Chalius, H.H.; Ghani, G.; Geldmacher, H.; Henke, I.W.; Kindermann, L.; Marks, V. 1976: Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion Geburtshilfe und Frauenheilkunde 36(6): 485-492
Rüfenacht, R.; Morell 1991: Immunochemical characterization of intravenous immunoglobulin preparations Allergologia et Immunopathologia 19(5): 197-200
Nydegger, U.E. 1983: Evaluation criteria for intravenous immunoglobulin G preparations Presse Medicale 12(41): 2619-2624
Guencheva, G. 1984: Requirements and characteristics of various immunoglobulin preparations for intravenous application Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 30(1): 21-23
Siwińska-Gołebiowska, H.; Czerwińska-Kartowicz, I.; Markiewicz, K. 2002: Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies Postepy Higieny i Medycyny Doswiadczalnej 56 Suppl: 33-40
Stephan, W.; Dichtelmüller, H. 1983: Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations Arzneimittel-Forschung 33(9): 1230-1231
González Pacheco, M.; Pérez de la Mora, C.; Ruíz Puente, J.; Pérez de la Mora, S. 1984: Elaboration of a national reference preparation of lyophilized tetanus antitoxin Revista Latinoamericana de Microbiologia 26(1): 9-13
Malov, V.V.; Buidenok, T.V. 1972: Treatment of siderosilicotuberculosis patients with intravenous administration of antibacterial preparations Problemy Tuberkuleza 50(6): 66-67
Maltbaek, N.; Harreby, M.S.; Thøgersen, B. 1994: Intravenous immunoglobulin administration to a patient with systemic lupus erythematosus and pneumococcal septicemia Ugeskrift for Laeger 156(27): 4039-4041
Vorob'eva, V.A.; Shilenok, I.G.; Azova, E.A.; Darovskaia, T.E.; Repina, A.N.; Kiseleva, I.A.; Anastasiev, V.V.; Budtsina, M.V. 1990: Human immunoglobulin for intravenous administration in the treatment of infectious and inflammatory diseases in children Pediatriia 8: 74-78
Sapozhnikova, V.S.; Dumkin, I.M. 1994: The preventive properties and therapeutic efficacy of an antitetanus immunoglobulin for experimental intravenous administration Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1994(4): 81-84
Bagli, M.; Rao, M.L.; Höflich, G.; Kasper, S.; Langer, M.; Barlage, U.; Beneke, M.; Süverkrüp, R.; Möller, H.J. 1996: Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations Arzneimittel-Forschung 46(3): 247-250
Radkevich, R.A.; Utkin, V.V.; Gushanskiĭ, A.M. 1970: Effect of intravenous administration of 1st series preparations on blood coagulation in pulmonary and renal tuberculosis Problemy Tuberkuleza 48(7): 31-35
Winder, A.; Molad, Y.; Ostfeld, I.; Kenet, G.; Pinkhas, J.; Sidi, Y. 1993: Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases Journal of Rheumatology 20(3): 495-498
Mikhaĭlova, E.S.; Vilenskaia, R.N.; Kanevskaia, S.S. 1974: Intravenous administration of antitubercular preparations in the complex treatment of patients with pulmonary tuberculosis associated with peptic ulcer Terapevticheskii Arkhiv 46(5): 129-133
Nürnberger, W.; Willers, R.; Körholz, D.; Göbel, U.; Wahn, V. 1988: Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. I. Anticomplementary activity of gamma globulin preparations is a function of the preparation and IgG concentration prior to infusions Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 136(3): 116-120
Zharkov, S.A.; Batov, S.V. 1988: Elaboration of the combination of antitumor preparations bleomycetin + 5-fluorouracil + cisplatin Antibiotiki i Khimioterapiia 33(11): 859-861